C
Carlo M. Croce
Researcher at Ohio State University
Publications - 1156
Citations - 199822
Carlo M. Croce is an academic researcher from Ohio State University. The author has contributed to research in topics: microRNA & Cancer. The author has an hindex of 198, co-authored 1135 publications receiving 189007 citations. Previous affiliations of Carlo M. Croce include University of Nebraska Medical Center & University of California, Los Angeles.
Papers
More filters
Journal ArticleDOI
NOTCH1 mutations in CLL associated with trisomy 12
Veronica Balatti,Arianna Bottoni,Alexey Palamarchuk,Hansjuerg Alder,Laura Z. Rassenti,Thomas J. Kipps,Yuri Pekarsky,Carlo M. Croce +7 more
TL;DR: In this paper, the results of sequencing of XPO1 and NOTCH1 in 186 CLL cases were reported, and the results confirmed frequency of notch1 mutations in 2.4% of cases, while notCH1 was found mutated in 12.2% or 15.1% of CLL samples.
Journal ArticleDOI
Expression and prognostic impact of lncRNAs in acute myeloid leukemia.
Ramiro Garzon,Stefano Volinia,Dimitrios Papaioannou,Deedra Nicolet,Jessica Kohlschmidt,Jessica Kohlschmidt,Pearlly S. Yan,Krzysztof Mrózek,Donna Bucci,Andrew J. Carroll,Maria R. Baer,Meir Wetzler,Thomas H. Carter,Bayard L. Powell,Jonathan E. Kolitz,Joseph O. Moore,Ann-Kathrin Eisfeld,James S. Blachly,William Blum,Michael A. Caligiuri,Richard Stone,Guido Marcucci,Carlo M. Croce,John C. Byrd,Clara D. Bloomfield +24 more
TL;DR: It is shown that lncRNA expression profiles are associated with recurrent mutations, clinical features, and outcome in acute myeloid leukemia (AML), and a small subset of lncRNAs is correlated strongly with treatment response and survival.
Journal ArticleDOI
Association of Inflammation-Related and microRNA Gene Expression with Cancer-Specific Mortality of Colon Adenocarcinoma
Aaron J. Schetter,Giang Nguyen,Elise D. Bowman,Ewy Mathé,Siu Tsan Yuen,Jason E. Hawkes,Carlo M. Croce,Suet Yi Leung,Curtis C. Harris +8 more
TL;DR: Both IRS and miR-21 expression were independently associated with cancer-specific mortality, including stage II patients alone, and may provide a clinically useful tool to identify high-risk patients.
Journal Article
Structure and expression of the human FHIT gene in normal and tumor cells.
Teresa Druck,Piotr Hadaczek,Tie-bo Fu,Masataka Ohta,Zurab Siprashvili,Raffaele Baffa,Massimo Negrini,Kumar Kastury,Maria Luisa Veronese,David Rosen,Jay L. Rothstein,Peter McCue,Maria Grazia Cotticelli,Hiroshi Inoue,Carlo M. Croce,Kay Huebner +15 more
TL;DR: The FHIT gene, encoded by 10 exons in a 1.1-kb transcript, encompasses approximately 1 Mb of genomic DNA, which includes the hereditary RCC t(3;8) translocation break at 3p14.2, the FRA3B common fragile region, and homozygous deleting in various cancer-derived cell lines.
Journal ArticleDOI
Transcriptionally active c-myc oncogene is contained within NIARD, a DNA sequence associated with chromosome translocations in B-cell neoplasia.
Kenneth B. Marcu,Linda J. Harris,Lawrence W. Stanton,Jan Erikson,Rosemary Watt,Carlo M. Croce +5 more
TL;DR: DNA sequences adjacent to the human c-myc gene recombined with the C(mu) immunoglobulin gene locus on chromosome 14 in several Burkitt lymphomas, implicates its involvement in B-cell oncogenesis.